Wikipedia:Articles for deletion/Sulfad


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was redirect to Silibinin. And merge as editors may desire. Not much discussion, but nobody is for keeping this as a separate article.  Sandstein  10:43, 6 December 2015 (UTC)

Sulfad

 * – ( View AfD View log  Stats )

No coverage in the secondary biomedical literature so fals WP:GNG. Alexbrn (talk) 16:40, 13 November 2015 (UTC)  Relisted to generate a more thorough discussion and clearer consensus.
 * Delete: Much of the coverage I found felt like it was some kind of WP:FRINGE stuff... Perhaps this is a case of WP:NOTADVOCATE mixed with WP:PROFRINGE? Whatever the case, it fails WP:GNG. Ceosad (talk) 23:59, 13 November 2015 (UTC)
 * Not sure maybe Merge to Silibinin This seems to be a drug that is a formulation of Silibinin. Wikipedia does not have good coverage of drug formulations and articles on these are welcome, but need solid sources. The sources cited here are primary research and case studies and not WP:MEDRS.  Blue Rasberry   (talk)  16:08, 20 November 2015 (UTC)

Please add new comments below this notice. Thanks, North America1000 03:25, 21 November 2015 (UTC)
 * Note: This debate has been included in the list of Medicine-related deletion discussions. Shawn in Montreal (talk) 21:58, 22 November 2015 (UTC)

 Relisted to generate a more thorough discussion and clearer consensus.

Please add new comments below this notice. Thanks, Sam Sailor Talk! 01:50, 28 November 2015 (UTC)  Relisted to generate a more thorough discussion and clearer consensus.

Please add new comments below this notice. Thanks, The Bushranger One ping only 10:38, 6 December 2015 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.